BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 32194550)

  • 21. Gut dendritic cell activation links an altered colonic microbiome to mucosal and systemic T-cell activation in untreated HIV-1 infection.
    Dillon SM; Lee EJ; Kotter CV; Austin GL; Gianella S; Siewe B; Smith DM; Landay AL; McManus MC; Robertson CE; Frank DN; McCarter MD; Wilson CC
    Mucosal Immunol; 2016 Jan; 9(1):24-37. PubMed ID: 25921339
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Expression of TIM-3 on Plasmacytoid Dendritic Cells as a Predictive Biomarker of Decline in HIV-1 RNA Level during ART.
    Font-Haro A; Janovec V; Hofman T; Machala L; Jilich D; Melkova Z; Weber J; Trejbalova K; Hirsch I
    Viruses; 2018 Mar; 10(4):. PubMed ID: 29597250
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Rapid CD4 decline prior to antiretroviral therapy predicts subsequent failure to reconstitute despite HIV viral suppression.
    Darraj M; Shafer LA; Chan S; Kasper K; Keynan Y
    J Infect Public Health; 2018; 11(2):265-269. PubMed ID: 28826735
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Activated dendritic cells and monocytes in HIV immunological nonresponders: HIV-induced interferon-inducible protein-10 correlates with low future CD4+ recovery.
    Stiksrud B; Aass HCD; Lorvik KB; Ueland T; Trøseid M; Dyrhol-Riise AM
    AIDS; 2019 Jun; 33(7):1117-1129. PubMed ID: 30789356
    [TBL] [Abstract][Full Text] [Related]  

  • 25. HIV infection affects blood myeloid dendritic cells after successful therapy and despite nonprogressing clinical disease.
    Fontaine J; Coutlée F; Tremblay C; Routy JP; Poudrier J; Roger M;
    J Infect Dis; 2009 Apr; 199(7):1007-18. PubMed ID: 19231994
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Blood Myeloid Dendritic Cells and slanDC in Antiretroviral Therapy- Suppressed HIV-Infected Patients.
    Lichtner M; Rossi R; Vita S; Savinelli S; Iannetta M; Mascia C; Marocco R; Ajassa C; Mengoni F; Scorzolini L; Maria Mastroianni C; Vullo V
    Curr HIV Res; 2016; 14(4):331-9. PubMed ID: 26785889
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Baseline Characteristics of Mitochondrial DNA and Mutations Associated With Short-Term Posttreatment CD4+T-Cell Recovery in Chinese People With HIV.
    Liu A; Wei Q; Lin H; Ding Y; Sun YV; Zhao D; He J; Ma Z; Li F; Zhou S; Chen X; Shen W; Gao M; He N
    Front Immunol; 2021; 12():793375. PubMed ID: 34970271
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Myeloid dendritic cells induce HIV-1 latency in non-proliferating CD4+ T cells.
    Evans VA; Kumar N; Filali A; Procopio FA; Yegorov O; Goulet JP; Saleh S; Haddad EK; da Fonseca Pereira C; Ellenberg PC; Sekaly RP; Cameron PU; Lewin SR
    PLoS Pathog; 2013; 9(12):e1003799. PubMed ID: 24339779
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Selective impairments in dendritic cell-associated function distinguish hepatitis C virus and HIV infection.
    Anthony DD; Yonkers NL; Post AB; Asaad R; Heinzel FP; Lederman MM; Lehmann PV; Valdez H
    J Immunol; 2004 Apr; 172(8):4907-16. PubMed ID: 15067070
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Persistent abnormalities in peripheral blood dendritic cells and monocytes from HIV-1-positive patients after 1 year of antiretroviral therapy.
    Almeida M; Cordero M; Almeida J; Orfao A
    J Acquir Immune Defic Syndr; 2006 Apr; 41(4):405-15. PubMed ID: 16652047
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Defective dendritic cell function in HIV-infected patients receiving effective highly active antiretroviral therapy: neutralization of IL-10 production and depletion of CD4+CD25+ T cells restore high levels of HIV-specific CD4+ T cell responses induced by dendritic cells generated in the presence of IFN-alpha.
    Carbonneil C; Donkova-Petrini V; Aouba A; Weiss L
    J Immunol; 2004 Jun; 172(12):7832-40. PubMed ID: 15187167
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Macrophages and Myeloid Dendritic Cells Lose T Cell-Stimulating Function in Simian Immunodeficiency Virus Infection Associated with Diminished IL-12 and IFN-α Production.
    Wonderlich ER; Wu WC; Normolle DP; Barratt-Boyes SM
    J Immunol; 2015 Oct; 195(7):3284-92. PubMed ID: 26297760
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Chinese human immunodeficiency virus-1 patients with different routes of transmission exhibit altered expression levels of blood dendritic cell subpopulations.
    Zhao JL; Hao S; Feng MM; Li PF; Gong W; Xu XQ; Huan XP; Fu GF; Hou YY
    Viral Immunol; 2011 Feb; 24(1):35-43. PubMed ID: 21319977
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Type 1-programmed dendritic cells drive antigen-specific latency reversal and immune elimination of persistent HIV-1.
    Kristoff J; Palma ML; Garcia-Bates TM; Shen C; Sluis-Cremer N; Gupta P; Rinaldo CR; Mailliard RB
    EBioMedicine; 2019 May; 43():295-306. PubMed ID: 30952614
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Delayed antiretroviral therapy in HIV-infected individuals leads to irreversible depletion of skin- and mucosa-resident memory T cells.
    Saluzzo S; Pandey RV; Gail LM; Dingelmaier-Hovorka R; Kleissl L; Shaw L; Reininger B; Atzmüller D; Strobl J; Touzeau-Römer V; Beer A; Staud C; Rieger A; Farlik M; Weninger W; Stingl G; Stary G
    Immunity; 2021 Dec; 54(12):2842-2858.e5. PubMed ID: 34813775
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Interleukin 23 produced by myeloid dendritic cells contributes to T-cell dysfunction in HIV type 1 infection by inducing SOCS1 expression.
    Garg A; Rawat P; Spector SA
    J Infect Dis; 2015 Mar; 211(5):755-68. PubMed ID: 25234720
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Persistent low viral load on antiretroviral therapy is associated with T cell-mediated control of HIV replication.
    Alatrakchi N; Duvivier C; Costagliola D; Samri A; Marcelin AG; Kamkamidze G; Astriti M; Agher R; Calvez V; Autran B; Katlama C
    AIDS; 2005 Jan; 19(1):25-33. PubMed ID: 15627030
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Monocyte derived dendritic cells from HIV-1 infected individuals partially reconstitute CD4 T-cell responses.
    Newton PJ; Weller IV; Williams IG; Miller RF; Copas A; Tedder RS; Katz DR; Chain BM
    AIDS; 2006 Jan; 20(2):171-80. PubMed ID: 16511409
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Opposing roles of blood myeloid and plasmacytoid dendritic cells in HIV-1 infection of T cells: transmission facilitation versus replication inhibition.
    Groot F; van Capel TM; Kapsenberg ML; Berkhout B; de Jong EC
    Blood; 2006 Sep; 108(6):1957-64. PubMed ID: 16705088
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Biological determinants of immune reconstitution in HIV-infected patients receiving antiretroviral therapy: the role of interleukin 7 and interleukin 7 receptor α and microbial translocation.
    Rajasuriar R; Booth D; Solomon A; Chua K; Spelman T; Gouillou M; Schlub TE; Davenport M; Crowe S; Elliott J; Hoy J; Fairley C; Stewart G; Cameron P; Lewin SR
    J Infect Dis; 2010 Oct; 202(8):1254-64. PubMed ID: 20812848
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.